From: CD209 in inflammatory bowel disease: a case-control study in the Spanish population
Ulcerative colitis | |
---|---|
Sex (% M) | 55 |
Mean (SD) age at onset (y) | 35.1 (12.9) |
Mean (SD) disease duration (y) | 10.1 (7.1) |
Smoking habits (%) | |
Never | 47.1 |
Ex/current | 52.9 |
Extraintestinal manifestations (%) | 44.4 |
Disease location (%) | |
Left sided (including proctitis) | 56.5 |
Extensive colitis/Pancolitis | 43.5 |
Surgery (%) | 13.8 |
Immunosupression (%) | 24.4 |
Crohn's disease | |
Sex (% M) | 49.1 |
Mean (SD) age at onset (y) | 28.3 (12.5) |
<40 (A1) | 81.2 |
>40 (A2) | 18.8 |
Mean (SD) disease duration (y) | 9.4 (6.3) |
Smoking habits (%) | |
Never | 51.5 |
Ex/current | 48.5 |
Disease location | |
Ileal (L1) | 43.2 |
Colonic (L2) | 17.2 |
Ileocolonic (L3) | 35.0 |
Upper GI tract (L4) | 4.5 |
Disease Behavior | |
Inflammatory (B1) | 40.9 |
Stricturing (B2) | 19.3 |
Perforating (B3) | 39.8 |